GB2048671B - Pharmaceutical composition containing dihydroegotoxine - Google Patents

Pharmaceutical composition containing dihydroegotoxine

Info

Publication number
GB2048671B
GB2048671B GB8012357A GB8012357A GB2048671B GB 2048671 B GB2048671 B GB 2048671B GB 8012357 A GB8012357 A GB 8012357A GB 8012357 A GB8012357 A GB 8012357A GB 2048671 B GB2048671 B GB 2048671B
Authority
GB
United Kingdom
Prior art keywords
dihydroegotoxine
pharmaceutical composition
composition containing
pharmaceutical
containing dihydroegotoxine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8012357A
Other versions
GB2048671A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of GB2048671A publication Critical patent/GB2048671A/en
Application granted granted Critical
Publication of GB2048671B publication Critical patent/GB2048671B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8012357A 1979-04-26 1980-04-15 Pharmaceutical composition containing dihydroegotoxine Expired GB2048671B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7910620A FR2454804B1 (en) 1979-04-26 1979-04-26 DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME

Publications (2)

Publication Number Publication Date
GB2048671A GB2048671A (en) 1980-12-17
GB2048671B true GB2048671B (en) 1983-07-13

Family

ID=9224784

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8012357A Expired GB2048671B (en) 1979-04-26 1980-04-15 Pharmaceutical composition containing dihydroegotoxine

Country Status (6)

Country Link
BE (1) BE882913A (en)
ES (1) ES8103970A1 (en)
FR (1) FR2454804B1 (en)
GB (1) GB2048671B (en)
IL (1) IL59764A (en)
IT (1) IT1130109B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534139B1 (en) * 1982-10-07 1986-08-29 Laruelle Claude NOVEL GALENIC FORM OF SULPIRIDE, METHOD FOR PREPARING SAME, AND MEDICINAL PRODUCT COMPRISING THIS NEW FORM
FR2539995B1 (en) * 1983-01-28 1985-08-16 Sanofi Sa PROGRAMMED RELEASE MEDICINE BASED ON ACETYLSALICYLIC ACID
FR2539989B1 (en) * 1983-01-28 1985-08-09 Sanofi Sa PROGRAMMED RELEASE MEDICINE COMBINING ACETYLSALICYLIC ACID WITH DIHYDROERGOTAMINE
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
CN102266310B (en) * 2011-07-21 2014-01-15 佛山市隆信医药科技有限公司 Dihydroergotoxine mesylate sustained-release capsule and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1347413A (en) * 1963-01-29 1963-12-27 Italnysco S P A Broad-acting spherules or globules and method for their preparation
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids
DE2010416B2 (en) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Orally applicable dosage form with sustained release effect
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
LU77353A1 (en) * 1977-05-16 1979-01-19

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions

Also Published As

Publication number Publication date
IT8067531A0 (en) 1980-04-04
IT1130109B (en) 1986-06-11
IL59764A (en) 1984-06-29
BE882913A (en) 1980-08-18
ES491455A0 (en) 1981-04-16
FR2454804A1 (en) 1980-11-21
IL59764A0 (en) 1980-06-30
FR2454804B1 (en) 1986-11-21
GB2048671A (en) 1980-12-17
ES8103970A1 (en) 1981-04-16

Similar Documents

Publication Publication Date Title
GB2039738B (en) Inflammation - preventing pharmaceutical composition
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
GB2057263B (en) Compositions containing methylsulphonylmethane
JPS54132223A (en) Novel pharmaceutical composition
ZA813465B (en) Pharmaceutical composition
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
IL61117A0 (en) Acetoxymethyl-penem compounds and pharmaceutical compositions containing them
JPS5691075A (en) Size composition
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
ZA805666B (en) Pharmaceutical compositions containing paracetamol
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
ZA802009B (en) Pharmaceutical compounds
NZ192021A (en) Pharmaceutical compositions containing aryltrifluoroethanols
ZA806383B (en) Long acting pharmaceutical composition
DE3064666D1 (en) Pharmaceutical compositions containing paracetamol
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
JPS54154516A (en) Pharmaceutical composition
GB2055042B (en) Pharmaceutical compositions containing substituted biruets compound
PH15118A (en) Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
IL60600A (en) Pharmaceutical compositions comprising certain azolylalkenol compounds

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20000414